Alexandrine Jaecklin
Portfolio Manager-Fixed Income at Bellevue Asset Management AG
Profile
Ms. Alexandrine Jaecklin is a Lead Portfolio Manager at Bellevue Asset Management AG.
She joined the firm in 2015.
Before that, Ms. Jaecklin spent over 15 years at UBS, where she worked as a research analyst covering European financial credits and later as an investment specialist for UHNW clients, focusing on bond markets.
She holds a master in International Relations & Graduate from Institute of International Studies in Geneva.
Alexandrine Jaecklin active positions
| Companies | Position | Start |
|---|---|---|
Bellevue Asset Management AG
 Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Portfolio Manager-Fixed Income | 31/12/2022 |
Former positions of Alexandrine Jaecklin
| Companies | Position | End |
|---|---|---|
| Laidlaw Global Securities, Inc. | Analyst-Equity | 10/05/1999 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
| Laidlaw Global Securities, Inc. | Finance |
Bellevue Asset Management AG
Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Finance |
- Stock Market
- Insiders
- Alexandrine Jaecklin
